SCHEMBL3185170

SCHEMBL3185170

CCCCCC([O])O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6949281 0.97 GPR84 (0.56)
SCHEMBL8363305 0.97 GPR84 (0.56)
SCHEMBL27748657 0.97 GPR84 (0.56)
SCHEMBL6651887 0.97 GPR84 (0.56)
SCHEMBL3175045 0.97
SCHEMBL7290380 0.97 GPR84 (0.56)
SCHEMBL6434519 0.97 GPR84 (0.56)
SCHEMBL28631358 0.97 GPR84 (0.56)
SCHEMBL6957833 0.97 GPR84 (0.56)
SCHEMBL3186368 0.97 GPR84 (0.56)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 118 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-107820496-B Tetracyclic 4-oxo-pyridine-3-carboxylic acid derivatives for the treatment and prevention of hepatitis B virus infections 豪夫迈·罗氏有限公司 2020-11-03 CN claimed
EP-3328855-B1 NOVEL TETRACYCLIC 4-OXO-PYRIDINE-3-CARBOXYLIC ACID DERIVATIVES FOR THE TREATMENT AND PROPHYLAXIS OF HEPATITIS B VIRUS INFECTION HOFFMANN LA ROCHE (CH) 2019-05-15 EP claimed
US-10053461-B2 Tetracyclic 4-oxo-pyridine-3-carboxylic acid derivatives for the treatment and prophylaxis of hepatitis B virus infection HOFFMANN-LA ROCHE INC. (US) 2018-08-21 US claimed
EP-3328855-A1 NOVEL TETRACYCLIC 4-OXO-PYRIDINE-3-CARBOXYLIC ACID DERIVATIVES FOR THE TREATMENT AND PROPHYLAXIS OF HEPATITIS B VIRUS INFECTION H. Hoffnabb-La Roche Ag (CH) 2018-06-06 EP claimed
US-20180127416-A1 NOVEL TETRACYCLIC 4-OXO-PYRIDINE-3-CARBOXYLIC ACID DERIVATIVES FOR THE TREATMENT AND PROPHYLAXIS OF HEPATITIS B VIRUS INFECTION HOFFMANN-LA ROCHE INC. (US) 2018-05-10 US claimed
US-9573887-B2 Naphthalene derivative DAITO CHEMIX CORPORATION (JP) 2017-02-21 US claimed
WO-2017017042-A1 NOVEL TETRACYCLIC 4-OXO-PYRIDINE-3-CARBOXYLIC ACID DERIVATIVES FOR THE TREATMENT AND PROPHYLAXIS OF HEPATITIS B VIRUS INFECTION F. HOFFMANN-LA ROCHE AG (CH) 2017-02-02 WO claimed
EP-1653960-A4 MELANIN CONCENTRATING HORMONE RECEPTOR ANTAGONIST AMGEN INC (US) 2008-11-26 EP claimed
EP-1653960-A2 MELANIN CONCENTRATING HORMONE RECEPTOR ANTAGONIST AMGEN INC. (US) 2006-05-10 EP claimed
US-20050215526-A1 Melanin concentrating hormone receptor antagonist AMGEN, INC. 2005-09-29 US claimed
WO-2005019167-A2 MELANIN CONCENTRATING HORMONE RECEPTOR ANTAGONIST AMGEN, INC. (US) 2005-03-03 WO claimed
US-6287648-B1 MIXTURE OF POLAR COMPOUNDS HAVING POSITIVE DIELECTRIC ANISTROPY MERCK PATENT GESELLSCHAFT MIT (DE) 2001-09-11 US claimed
US-5770672-A Catalyst for low temperature cure of blocked isocyanates ELF ATOCHEM NORTH AMERICA, INC. (US) 1998-06-23 US claimed
EP-0810245-A1 Catalyst for low temperature cure of blocked isocyanates ELF ATOCHEM NORTH AMERICA, INC. (US) 1997-12-03 EP claimed
EP-0535588-B1 A method of imparting durable press properties to cotton textiles without using formaldehyde OSI SPECIALTIES INC (US) 1996-02-14 EP claimed
US-5310418-A Cyclic acetal of glutaraldehyde UNION CARBIDE CHEMICALS & PLASTICS TECHNOLOGY CORPORATION (US) 1994-05-10 US claimed
EP-0535588-A1 A method of imparting durable press properties to cotton textiles without using formaldehyde OSi Specialties, Inc. (US) 1993-04-07 EP claimed
CN-105611920-B Preparation of hydroxy-diphenylmethane derivatives 泰拉科斯萨普有限责任公司 2021-07-16 CN disclosed
CN-1046529-A Carbostyril derivative OTSUKA PHARMA CO LTD (JP) 1990-10-31 CN disclosed
EP-0382185-A2 Carbostyril derivatives OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1990-08-16 EP disclosed